Abstract:One of the hallmarks of the LH induced granulosa-luteal transition is a conversion from a proliferative, estrogen producing granulosa cell to a differentiated, progestin secreting luteal cell. The B Cell Translocation Gene (BTG) family has been reported to be involved in cell differentiation, antiproliferation, and gene transcription regulation. We hypothesized that BTGs are involved in this process, however, very little is known about them in the ovary. The present study investigated the spatiotemporal expression pattern, regulation and potential function of BTG1, BTG2, and BTG3 in the rat ovary during the periovulatory period. Immature 22-23 days old rats were injected with eCG (10 IU) s.c. to stimulate follicular development and 48h later with hCG (5 IU) s.c. to induce ovulation and subsequent formation of corpora lutea (CL). Animals were killed at different time points after hCG administration (n=3/time point). Ovaries were collected for isolation of total RNA or protein, or processed for in situ hybridization. Granulosa cells were also collected in vivo at different time points for isolation of total RNA or protein. Quantitative real-time PCR analysis revealed that mRNA for Btg1, Btg2, and Btg3 was highly induced both in intact ovaries and granulosa cells by 4 to 8h after hCG stimulation. The expression of Btg1 mRNA in whole ovary was highest between 4 and 8h before decreasing to control levels by 12 and 24h after hCG. The levels of Btg1 mRNA exhibited a similar expression pattern in the granulosa cells (in vivo) to that observed in the whole ovary with the highest expression at 8h. Btg2 mRNA expression in whole ovaries increased 6.5 fold at 4 and 8h after hCG but did not decrease to control levels by 24h, whereas its expression in the granulosa cells (in vivo) continued to increase until 24h after hCG treatment. Btg3 mRNA levels increased 3 fold at 8h after hCG and remained elevated throughout the periovulatory period in both granulosa cells (in vivo) and the whole ovary. In situ hybridization showed that Btg1 mRNA expression was induced in the theca and granulosa cells of some follicles at 4h after hCG injection. Strikingly, there was a switch in the expression from the theca to the granulosa cell compartment at 8 and 12h after hCG. After ovulation, Btg1 mRNA expression was similar to the 0h ovary with little detectable signal in the forming CL. In contrast, Btg2 mRNA expression level was high in luteal cells at 24h after hCG administration. Btg3 mRNA was induced at 8h in granulosa cells after hCG treatment. Regulation of Btg expression was then examined using cultured granulosa cells. Inhibition of progesterone action and the EGF pathway did not change Btg1 and Btg2 mRNA expression, whereas inhibition of prostaglandin synthesis or RUNX activity diminished Btg2 mRNA levels. To determine the function of the BTGs, overexpression of BTG1 or BTG2 resulted in an increase in the percentage of granulosa cells in the G0/G1 phase, whereas the percentage of cells in the S phase decreased. The apoptosis rate in the granulosa cells overexpressing BTG1 or BTG2 also decreased compared to cells infected with the control GFP vector. In conclusion, the induction of BTG1, BTG2, and BTG3 expression after hCG administration and the ability to arrest the cell cycle may be related to theca and granulosa cells differentiation or the establishment of quiescence. (Supported by NIH RR15592 and AG17164)

Btg1 Expression Correlates With The Pathogenesis And Progression Of Ovarian Carcinomas

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis

BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer via Decreasing Adhesion and Inducing Epithelial–Mesenchymal Transition

High Expression of ENPP1 in High-Grade Serous Ovarian Carcinoma Predicts Poor Prognosis and As a Molecular Therapy Target.

Decreased Expression of BTG3 Was Linked to Carcinogenesis, Aggressiveness, and Prognosis of Ovarian Carcinoma

B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.

The B Cell Translocation Gene (BTG) Family in the Rat Ovary: Hormonal Induction, Regulation, and Impact on Cell Cycle Kinetics.

Btg1 Inhibits Breast Cancer Cell Growth Through Induction Of Cell Cycle Arrest And Apoptosis

The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis

Transcriptomic Analyses Reveal B-Cell Translocation Gene 2 as a Potential Therapeutic Target in Ovarian Cancer

Sugt1 Regulates the Progression of Ovarian Cancer Through the Akt/Pi3k/Mtor Signaling Pathway

Expression of BTG1 in Renal Clear Cell Carcinoma and Its Role in 786-O Cell Proliferation and Apoptosis in Vitro

Expression of BTG1 in HK-2 and 786-O and Its Influence on Cell Cycle and Apoptosis of HK-2 and 786-O

The effect of BTG1 expression on proliferation, apoptosis and invasion of non-small cell lung cancer cells

Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer

BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1.

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma

Upregulation of BTG1 Enhances the Radiation Sensitivity of Human Breast Cancer in Vitro and in Vivo

Evaluation of the Role of ITGBL1 in Ovarian Cancer

Alteration of HGF and TSP-1 expression in ovarian carcinoma associated with clinical features.